Skip to search formSkip to main contentSkip to account menu

hydroperoxyisophosphamide

Known as: 4-hydroperoxyifosfamide, NSC-227114 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
“Acquired” insensitivity to cyclophosphamide and theroxazaphosphorines, e.g., 4-ydroperoxycyclophosphamide (4HC), mafosfamide… 
1997
1997
Amifostine (WR-2721) is currently being investigated as a potential protector of normal tissues during chemotherapy in adult and… 
1996
1996
We analyzed the effects of ifosfamide, a chemotherapeutic agent that is broadly used within anticancer therapy, on… 
1995
1995
There is ongoing interest in the selective, quantitative analysis of the cyclophosphamide metabolites 4-hydroxycyclophosphamide… 
1994
1994
We studied the effects of ifosfamide and major motabolites on intracellular glutathlone (GSH) levels in human peripheral blood… 
1994
1994
31P nuclear magnetic resonance (NMR) spectroscopy was used in conjunction with cell perfusion techniques to monitor the… 
1977
1977
4-Hydroperoxyisophosphamide and its analogues were simply synthesized by ozonolysis reactions of O-(3-butenyl)-N, N'-bis (2… 
1976
1976
A one-step synthesis of 4-hydroperoxyifosfamide and 4-hydroperoxytrofosfamide is described. The method involves direct ozonation… 
1976
1976
An acid-catalyzed isomerization of 4-hydroperoxyisophosphamide, a synthetic compound with potential antitumor activity, produced…